Please login to the form below
product launches
This page shows the latest product launches news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca and Ionis sign $3.6bn deal for eplontersen
2022. The AZ deal bolsters Ionis' commercial organisation as it prepares for multiple product launches.
Latest news
-
BMS’ Q2 results beat expectations with strong performance across core therapy areas
We delivered a strong quarter across each of our four therapeutic areas, including building momentum for our new product portfolio and Opdivo returning to growth,” said Giovanni Caforio, board chair and ... As we move forward, we remain focused on
-
GSK aims for £33bn in sales by 2031 as CEO Walmsley lays out ten-year strategy
The company will use these funds to strengthen its pipeline, invest in successful product launches, enhance the sustainability of its operations and underpin its ‘progressive’ dividend policy. ... By 2031, GSK is expecting product sales to reach
-
W2O rebrands as ‘health innovation company’ Real Chemistry
Real Chemistry can do this for clinical trials, new product launches and commercialisation opportunities – all focused on successfully navigating product lifecycles to ultimately improve health outcomes, in partnership with our clients,”
-
Teva’s weak pipeline hit by Tourette’s drug trial failure
Drug wasn't able to improve on placebo. Teva’s effort to reinvigorate its business with new product launches has suffered a setback after a drug for Tourette’s syndrome failed ... Full-year growth was higher at more than 100%. Teva said before the
-
Pharma Brand Planners' Blog (Part 7)
A few statistics feel useful here to support our theme:. Across all major industries, 72% of all product launches fail to meet their revenue targets.
More from news
Approximately 0 fully matching, plus 131 partially matching documents found.
Latest Intelligence
-
Listen, learn and lift off
The pandemic storms have changed the atmospherics of product launches, which now fire off at all angles and timings – like a box of fireworks introduced to a stray match. ... Use data and the full toolbox. The real power available for product launches
-
Why pharma must get smart in its approach to customer engagement
Crucially, two of the five key imperatives it identifies for effective product launches are being customer-centric in the approach and incorporating analytics-driven personalisation and optimisation of channels to support
-
Product launches: making the most of your one shot
And according to IQVIA, fewer than 10% of launches are categorised as ‘excellent’. ... The same philosophy can be applied to product launches – if you’ve done it all perfectly once, why not reuse as much as you can the next time?
-
Beyoncé vs Paul Simon: achieving launch excellence
Despite this, they have two very different solo careers, requiring two very different launches. ... This must be someone you trust, who understands both pharma and product launches, and isn’t afraid of asking difficult questions.
-
Launch engagement
are all core components of effective product launches. ... Tailoring each launch. Launching a new product is never easy – 40% of worldwide drug launches between 2009 and 2017 failed to meet their two-year sales forecast, according to a McKinsey
More from intelligence
Approximately 0 fully matching, plus 27 partially matching documents found.
Latest appointments
-
New hire and promotions announced at Evoke KYNE
At Evoke KYNE, she has led a variety of communications initiatives across therapeutic areas, including patient advocacy relations, launches and product approvals.
-
New hires at bluebird bio, BioNTech and Provention Bio
In her new role, Heffron will be based in Zug, Switzerland, where she will aid the launch of bluebird’s first commercial product – its gene therapy Zynteglo. ... Jason's extensive commercial experience, including the planning, preparation and
-
Novo Nordisk target Ablynx reshuffles its board
Hensen is the ideal person to lead the board moving forward and his wealth of experience is particularly relevant as we advance towards the potential approvals and global launches of our ... lead, wholly-owned product, caplacizumab, in addition to
-
Astellas promotes John Demaree
In his new role, Demaree will lead the promotion of in-market products, the preparation of product launches and will collaborate with Astellas' partner organisations in the region on marketing strategy.
-
The Medicines Company appoints Biogen's Tony Kingsley
Kingsley previously served as Biogen's executive vice president, global commercial operations, where the product launches he oversaw included the multiple sclerosis blockbuster Tecfidera (dimethyl fumerate).
More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.
Latest from PMHub
-
Learning and development: the secret weapon for a successful life science launch
Dave Stuteville, Executive Vice President, Learning &Development, reveals the principles behind successfully training Sales Representatives and Medical Science Liaisons for a rapid biopharmaceutical product launch. ... In fact, research shows only 26%
-
The Contradiction Conundrum: New digital pharma report
For example, despite widespread understanding of the value of digital in pharma and the need to make it a future priority, only 4% of digital product launches are regularly succeeding. ... We hope that you find it an interesting and thought-provoking read
-
Listen, learn and lift off
Buckland points out that pandemic storms have changed the atmospherics of product launches, which now fire off at all angles and timings – like a box of fireworks introduced to a stray ... Product launches in this area also present commercial
-
VISFO appoints new Senior Advisor
With over 25+ years’ experience within the life sciences industry, Chris will be drawing upon his experience and network to accelerate VISFO’s product development and client offering. ... Chris has been responsible for leading some of the
-
Nucleus Global launches Nucleus X Consulting, a specialist consultancy with deep expertise in patient engagement, rare disease, and early-phase medical commercialization
Product launches are becoming progressively more challenging, with increased competition and pricing pressures, regulators demanding more evidence of therapeutic value, and patients driving treatment decisions and impacting on success through
More from PMHub
Approximately 1 fully matching, plus 58 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- How Resonant’s innovation and creativity resolve healthcare communications challenges
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Pfizer, Mylan move ahead with generics merger and spin-out
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
